The drug chapter segment of the SGLT2 inhibitors market report encloses the detailed analysis of SGLT2 inhibitors marketed drugs and late-stage (Phase-III and Phase-II) SGLT2 inhibitors pipeline drugs. It also helps to understand the SGLT2 inhibitors clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.